These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4274273)

  • 1. Depression of morphine-seeking behaviour by dopamine inhibition.
    Schwartz AS; Marchok PL
    Nature; 1974 Mar; 248(445):257-8. PubMed ID: 4274273
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in brain concentration of biogenic amines and the antinociceptive effect of morphine in rats.
    Reinhold K; Bläsig J; Herz A
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):69-80. PubMed ID: 4267967
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
    Andén NE; Corrodi H; Fuxe K
    J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
    Cooper BR; Grant LD; Breese GR
    Psychopharmacologia; 1973 Jul; 31(2):95-109. PubMed ID: 4722209
    [No Abstract]   [Full Text] [Related]  

  • 5. A mode of action of morphine on a quickly learned conditioned suppression in mice.
    Kameyama T; Nagasaka M
    J Pharmacobiodyn; 1984 Mar; 7(3):151-5. PubMed ID: 6235360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the influence of 6-hydroxydopamine, alpha methyltyrosine and 5,6-dihydroxy-tryptamine, p-chlorophenylalanine on the open field behaviour of rats.
    Kulkarni SK; Dandiya PC; Jain KM
    Indian J Physiol Pharmacol; 1974; 18(4):324-9. PubMed ID: 4282853
    [No Abstract]   [Full Text] [Related]  

  • 7. Operant behavior and catecholamine-containing neurons: prolonged increase in lever-pressing after 6-hydroxydopamine.
    Schoenfeld RI; Uretsky NJ
    Eur J Pharmacol; 1972 Dec; 20(3):357-62. PubMed ID: 4643457
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of neuroleptic drugs on the conditioned behavior after pretreatment with alpha-methyltyrosine or p-chlorophenylalanine.
    Oka M; Kamei C; Shimizu M
    Jpn J Pharmacol; 1977 Dec; 27(6):807-15. PubMed ID: 147354
    [No Abstract]   [Full Text] [Related]  

  • 9. Involvement of norepinephrine in transmission of the stimulatory influence of progesterone on gonadotropin release.
    Kalra PS; Kalra SP; Krulich L; Fawcett CP; McCann SM
    Endocrinology; 1972 May; 90(5):1168-76. PubMed ID: 4258973
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
    Antelman SM; Szechtman H; Chin P; Fisher AE
    J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha-methyltyrosine to prevent self-administration of morphine and amphetamine.
    Davis WM; Smith SG
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):814-9. PubMed ID: 4629822
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of alpha-methyl-p-tyrosine, p-chlorophenylalanine, l-beta-(3,4-dihydroxyphenyl)alanine, 5-hydroxytryptophan and diethyldithiocarbamate on the analgesic activity of morphine and methylamphetamine in the mouse.
    Major CT; Pleuvry BJ
    Br J Pharmacol; 1971 Aug; 42(4):512-21. PubMed ID: 4256024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of brain noradrenaline in morphine-induced stereotyped behaviour.
    Ayhan IH; Randrup A
    Psychopharmacologia; 1972; 27(3):203-12. PubMed ID: 4674514
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of brain monoamines in the anticonvulsant effect of imipramine in albino rats.
    Bhattacharya SK; Mukhopadhyay SN; Reddy PK; Das PK
    Pharmacology; 1976; 14(5):428-34. PubMed ID: 199912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a dopamine (DA)- -hydroxylase inhibitor on timing behavior.
    Ahlenius S; Engel J
    Psychopharmacologia; 1972; 24(2):243-6. PubMed ID: 5031056
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced dopaminergic supersensitivity.
    Moore KE; Thornburg JE
    Adv Neurol; 1975; 9():93-104. PubMed ID: 1146661
    [No Abstract]   [Full Text] [Related]  

  • 18. Stress-related effects of various inhibitors of catecholamine synthesis in the mouse.
    Thornburg JE; Moore KE
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):158-67. PubMed ID: 4399378
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced behavioral depressant effects of reserpine and -methyltyrosine after 6-hydroxydopamine treatment.
    Cooper BR; Breese GR; Howard JL; Grant LD
    Psychopharmacologia; 1972; 27(2):99-110. PubMed ID: 4638213
    [No Abstract]   [Full Text] [Related]  

  • 20. Catecholamine synthesis and the regulation of food intake in the rat.
    Friedman E; Starr N; Gershon S
    Life Sci I; 1973 Apr; 12(7):317-26. PubMed ID: 4695124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.